$417.52+25.30% · 3M
Moving avg
1W+2.62%
1M+11.36%
3M+26.82%
6M+29.11%
YTD+9.31%
1Y+42.24%
3Y+44.78%
5Y+2.30%
52-week range
$275.05100% of range$414.15
Company health
Value1/6
Growth2/6
Profitability6/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Strong 20% net margin
- High return on equity (804%)
Risks
- Richly valued at 47.8x earnings
Key statistics
Valuation
Market cap
$31.23B
Enterprise value
$29.65B
P/E ratio (TTM)
47.78x
P/S ratio (TTM)
6.51x
EV/EBITDA
32.07x
Per share & returns
EPS (TTM)
$5.47
Dividend yield
0.00%
Beta (1Y)
1.20
30-day change
+11.36%
Trading
Volume (24h)
217.90K
Previous close
$416.15
Shares outstanding
74.79M
About Waters Corporation
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
WAT
Waters Corporation is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker WAT.
Frequently asked questions
What is Waters Corporation's market cap?
Waters Corporation (WAT) has a market capitalization of $31.23B.
What is Waters Corporation's P/E ratio?
Waters Corporation trades at a price-to-earnings (P/E) ratio of 47.78.
What exchange does WAT trade on?
WAT trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,218.31-0.16%
$1.15T cap
Johnson & JohnsonJNJ
$261.30+0.17%
$629.71B cap
AbbVie Inc.ABBV
$250.30+0.62%
$442.23B cap
UnitedHealth Group IncorporatedUNH
$402.11-0.86%
$365.17B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.70+1.34%
$332.68B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.76B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap